An evaluation of continuation therapy with tricyclic antidepressants in depressive illness1 | Psychological Medicine | Cambridge Core (original) (raw)

Synopsis

A double-blind clinical trial has been carried out to ascertain whether patients making a good recovery from depressive illness with tricyclic antidepressant medication derive any benefit from continuation of therapy with the same drug at a lower dose level. Of the 92 patients who entered the trial significantly fewer on active treatment relapsed during the six-month trial period: 22% as compared with 50% of patients receiving placebo. Patients with residual symptoms on entry to the trial derived more benefit from continuation therapy than patients who had made a complete recovery. The findings relate to a six-month trial period only, and any possible advantage of continuation therapy over a longer period remains uncertain.

References

Armitage, P. (1971). In Statistical Methods in Medical Research. Blackwell: Oxford.Google Scholar

Blashki, T. G., Mowbray, R., and Davies, B. (1971). Controlled trial of amitriptyline in general practice. British Medical Journal, 1, 133–138.CrossRefGoogle ScholarPubMed

Boston Collaborative Drug Surveillance Program (1972). Adverse reactions to the tricyclic-antidepressant drugs. Lancet, 1, 529–531.Google Scholar

Burt, C. G., Gordon, W. F., Holt, N. F., and Hordern, A. (1962). Amitriptyline in depressive states: a controlled trial. Journal of Mental Science, 108, 711–730.CrossRefGoogle ScholarPubMed

Coull, D. C., Crooks, J., Dingwall-Fordyce, I., Scott, A. M., and Weir, R. D. (1970). Amitriptyline and cardiac disease. Lancet, 2, 590–591.CrossRefGoogle ScholarPubMed

Elkes, A. (1969). Mode of Action of Imipramine, MD Thesis, University of London.Google Scholar

Hollister, L. E., Overall, J. E., Shelton, J., Pennington, V., Kimbell, I., and Johnson, M. (1967). Drug therapy of depression. Amitriptyline, perphenazine, and their combination in different syndromes. Archives of General Psychiatry, 17, 486–493.CrossRefGoogle ScholarPubMed

Imlah, N. W., Ryan, E., and Harrington, J. A. (1965). The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Journal of Neuro-Psychophamacology, 4, 438–442.Google Scholar

Kay, D. W. K., Fahy, T., and Garside, R. F. (1970). A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. British Journal of Psychiatry, 117, 667–671.CrossRefGoogle ScholarPubMed

Kuhn, R. (1958). The treatment of depressive states with G 22355 (imipramine hydrochloride). American Journal of Psychiatry, 115, 459–464.CrossRefGoogle Scholar

Leff, J. P., and Wing, J. K. (1971). Trial of maintenance therapy in schizophrenia. British Medical Journal, 3, 599–604.CrossRefGoogle ScholarPubMed

Leyburn, P. (1967). A critical look at antidepressant drug trials. Lancet, 2, 1135–1138.CrossRefGoogle Scholar

Lipsedge, M. S., Rees, W. L., and Pike, D. J. (1971). A double-blind comparison of dothiepin and amitriptyline for the treatment of depression with anxiety. Psychopharmacologia, 19, 153–162.CrossRefGoogle ScholarPubMed

Medical Research Council. (1965). Report by Clinical Psychiatry Committee. Clinical trial of the treatment of depressive illness. British Medical Journal, 1, 881–886.CrossRefGoogle Scholar

Paykel, E. S., Price, J. S., Gillan, R. U., Palmai, G., and Chesser, E. S. (1968). A comparative trial of imipramine and chlorpromazine in depressed patients. British Journal of Psychiatry, 114, 1281–1287.CrossRefGoogle ScholarPubMed

Paykel, E. S., Klerman, G. L., Dimascio, A., Weissman, M. M., and Prusoff, B. A. (1972). In Psychopathology and Psychopharmacology. Edited by Cole, J. O.. John Hopkins Press: Baltimore. (In press.)Google Scholar

Peto, R., and Peto, J. (1972). Asymptotically efficient rank invariant test procedures. Journal of the Royal Statistical Society, Scries B, 135, 185–206.CrossRefGoogle Scholar

Porter, A. M. W. (1970). Depressive illness in a general practice. A demographic study and a controlled trial of imipramine. British Medical Journal, 1, 773–778.CrossRefGoogle Scholar

Seager, C. P., and Bird, R. L. (1962). Imipramine with electrical treatment in depression-controlled trial. Journal of Mental Science, 108, 704–707.CrossRefGoogle ScholarPubMed

Shepherd, M., Lader, M., and Rodnight, R. (1968). Clinical Psychopharmacology. English Universities Press: London.Google Scholar

Wechsler, H., Grosser, G. H., Greenblatt, M. (1965). Research evaluating antidepressant medications on hospitalized mental patients: a survey of published reports during a five-year period. Journal of Nervous and Mental Disease, 141, 231–239.CrossRefGoogle ScholarPubMed

Willcox, D. R. C., Gillan, R., and Hare, E. H. (1965). Do psychiatric out-patients take their drugs? British Medical Journal, 2, 790–792.CrossRefGoogle Scholar

Wilson, J. D., and Enoch, M. D. (1967). Estimation of drug rejection by schizophrenic in-patients, with analysis of clinical factors. British Journal of Psychiatry, 113, 209–211.CrossRefGoogle ScholarPubMed